Maev is a technology company.
Maev has raised $19.0M across 2 funding rounds.
Maev has raised $19.0M in total across 2 funding rounds.
Maev is a pet nutrition company specializing in human-grade raw dog food, supplements, treats, and toppers formulated by PhD veterinary nutritionists to support canine health issues like digestion, mobility, anxiety, skin, and coat.[1][2][4] It serves dog owners seeking premium, unprocessed alternatives to conventional kibble, solving problems of low-quality ingredients, fillers, and preservatives in standard pet foods by offering AAFCO-compliant, science-backed products made with USDA proteins.[1][2][4] Founded in 2018 (with some sources noting 2019), Maev has raised $19M total, including a Series A-II round of $10M about three years ago, and reports 87% of surveyed customers seeing health improvements.[1][4]
Maev was founded by Katie Spies, an MIT-trained engineer and dog parent, inspired by her dog George's health scare, which prompted her to scrutinize commercial dog food and create a better option using human-grade ingredients.[1][2] Unable to find trustworthy products free of processed compromises, Spies developed Maev's raw food lineup with input from veterinary experts, launching in 2018 from New York City headquarters at 379 W Broadway.[1][2] Early traction came from George's transformation and word-of-mouth among dog owners, evolving into a direct-to-consumer brand with targeted formulas and a growing subscriber base.[1][2][4]
Maev rides the pet tech and direct-to-consumer wellness wave, leveraging e-commerce, subscription models, and data-driven nutrition amid rising demand for premium pet care—U.S. pet industry spending hit record highs pre-2025, fueled by humanization of pets post-pandemic.[1][4] Timing aligns with advances in veterinary science and supply chain tech for fresh raw delivery, countering market forces like inflation-hit mass-market kibble with high-margin, personalized alternatives.[2] It influences the ecosystem by normalizing raw feeding, partnering with influencers like Rumer Willis, and challenging incumbents through transparency and vet credentials, potentially expanding to tech integrations like health-tracking apps.[1][4]
Maev is poised for scaling via new proteins, international expansion, and potential tech add-ons like AI-personalized feeding plans, capitalizing on pet humanization and raw diet trends amid Series A momentum.[1][4] Evolving regulations on pet food standards and supply chain resilience will shape it, with influence growing through community loyalty and vet endorsements—watch for Series B to fuel DTC dominance. This raw revolution started with one dog's bowl, now filling thousands with science-backed nutrition.
Maev has raised $19.0M in total across 2 funding rounds.
Maev's investors include 11, Baukunst, Bolt, Contrary Capital, Springdale Ventures, VMG Partners, Wave Capital, Ron Pragides, Sean Harper.
Maev has raised $19.0M across 2 funding rounds. Most recently, it raised $10.0M Series A in September 2022.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Sep 1, 2022 | $10.0M Series A | 11, Baukunst, Bolt, Contrary Capital, Springdale Ventures, VMG Partners, Wave Capital, Ron Pragides, Sean Harper | |
| Dec 1, 2021 | $9.0M Seed | 11, Baukunst, Contrary Capital, Springdale Ventures, VMG Partners, Ron Pragides, Sean Harper |